JPRN-UMIN000036417已完成未知
Renal protective effect of tolvaptan in patients with new-onset acute heart failure - Renal protective effect of tolvaptan
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Concomitant acute coronary syndrome History of tolvaptan treatment before hospitalization Hemodialysis patient
研究者
相似试验
招募中
不适用
Study of the renal protective effect of tolvaptan as a replacement of loop diuretics for the treatment of ascites in cirrhotic patients with renal dysfunctioliver cirrhosisJPRN-UMIN000044693Tohoku Medical and Pharmaceutical University15
已完成
不适用
The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failurecongestive heart failureJPRN-UMIN000014134ishiarai Heart Center Hospital80
进行中（未招募）
1 期
The effects of tolvaptan on renal handeling of water and salt, hormones in the blood and the circulation, during blocking of the nitric oxide (NO) system in healthy subjects. A dose-response study.HyponatremiaSIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)MedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 100000004860EUCTR2013-003800-38-DKDepartment of Medical Research22
招募中
1 期
Tolvaptan for nephrogenic diabetes insipidusephrogenic diabetes insipidusNephrogenic diabetes insipidus, polyuriaD018500JPRN-jRCTs031180369Makita Noriko3
招募中
不适用
Efficacy and safety of tolvaptan in patients with severe aortic stenosis and chronic kidney disease undergoing transcatheter aortic valve replacementJPRN-UMIN000033577Tokyo Women's Medical University40